Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells

Clinical Immunology

Volumn 134, Issue 3, 2010, Pages 296-304

  Gredler, Viktoria ^a   Ebner, Susanne ^a   Schanda, Kathrin ^a   Forstner, Markus ^a   Berger, Thomas ^a   Romani, Nikolaus ^a   Reindl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Dendritic cells; Human; Multiple sclerosis; Myelin; Neuroimmunology

Indexed keywords

CHEMOKINE RECEPTOR CCR7; LIPOPOLYSACCHARIDE; MYELIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MULTIPLE SCLEROSIS; MYELIN SHEATH; PHAGOCYTOSIS; RECEPTORS, CCR7; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 76049109437     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.11.003     Document Type: Article

References (28)

1. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
2. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 354 (2006) 942-955
3. Lassmann H., Bruck W., and Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17 (2007) 210-218
4. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
5. Steinman L., Martin R., Bernard C., Conlon P., and Oksenberg J.R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25 (2002) 491-505
6. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., and Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 Pt. 6 (2000) 1174-1183
7. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., and Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
8. Matyszak M.K., and Perry V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74 (1996) 599-608
9. Pashenkov M., Huang Y.M., Kostulas V., Haglund M., Soderstrom M., and Link H. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124 (2001) 480-492
10. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G.L., and Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65 (2006) 124-141
11. Ifergan I., Kebir H., Bernard M., Wosik K., Dodelet-Devillers A., Cayrol R., Arbour N., and Prat A. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131 (2008) 785-799
12. Boven L.A., Van Meurs M., Van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., and Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129 (2006) 517-526
13. van Rossum D., Hilbert S., Strassenburg S., Hanisch U.K., and Bruck W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 56 (2008) 271-283
14. Liu Y., Hao W., Letiembre M., Walter S., Kulanga M., Neumann H., and Fassbender K. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 26 (2006) 12904-12913
15. van der Laan L.J., Ruuls S.R., Weber K.S., Lodder I.J., Dopp E.A., and Dijkstra C.D. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J. Neuroimmunol. 70 (1996) 145-152
16. Norton W.T., and Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21 (1973) 749-757
17. Bender A., Sapp M., Schuler G., Steinman R.M., and Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods. 196 (1996) 121-135
18. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., and Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196 (1996) 137-151
19. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
20. Ebner S., Hofer S., Nguyen V.A., Furhapter C., Herold M., Fritsch P., Heufler C., and Romani N. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J. Immunol. 168 (2002) 6199-6207
21. Ebner S., Ratzinger G., Krosbacher B., Schmuth M., Weiss A., Reider D., Kroczek R.A., Herold M., Heufler C., Fritsch P., and Romani N. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J. Immunol. 166 (2001) 633-641
22. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
23. Steinman R.M., Turley S., Mellman I., and Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191 (2000) 411-416
24. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16 (1998) 137-161
25. Weinberg A.D., Whitham R., Swain S.L., Morrison W.J., Wyrick G., Hoy C., Vandenbark A.A., and Offner H. Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J. Immunol. 148 (1992) 2109-2117
26. Veldhoen M., Hocking R.J., Flavell R.A., and Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7 (2006) 1151-1156
27. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13 (2007) 139-145
28. Ziegler E., Oberbarnscheidt M., Bulfone-Paus S., Forster R., Kunzendorf U., and Krautwald S. CCR7 signaling inhibits T cell proliferation. J. Immunol. 179 (2007) 6485-6493